1. Emilie Bourdonnay
  2. Thomas Henry  Is a corresponding author
  1. Inserm U1111, Université Lyon 1, Ecole Normale Supérieure, CNRS UMR5308, France

Infectious diseases are one of the main causes of death worldwide. Several of the most deadly bacterial pathogens, such as Salmonella enterica and Listeria monocytogenes, cause disease by multiplying inside human cells. The human body is constantly patrolled by immune cells, and contains lots of antibodies and other molecules that can target and kill microbes, but the environment inside host cells provides a safe haven where certain pathogens can avoid detection by the immune system. However, each host cell can contain only a limited number of these intracellular bacteria so, after several rounds of replication, they need to leave the infected cell and invade other cells in order to continue multiplying. Until recently the details of how intracellular bacteria can spread between cells without being detected and killed by the immune system were poorly understood.

Now, in eLife, Tom Kawula of the University of North Carolina and colleagues – including Shaun Steele as first author – report how experiments on Francisella tularensis, a bacterium that causes a disease known as tularemia, have revealed more details about this process (Steele et al., 2016). F. tularensis replicates in the cytosol of immune cells called macrophages and hundreds of them can live inside a single host cell (Celli and Zahrt, 2013). Previous studies have revealed that some intracellular bacteria, including L. monocytogenes, grow an actin tail in order to move between epithelial cells (Figure 1; Welch and Way, 2013). However, F. tularensis is unable to form an actin tail so it must rely on a different mechanism to spread around the body.

Intracellular bacteria can spread between host cells in different ways.

The environment surrounding the host cells is full of immune cells as well as proteins from the complement system (orange), defensins (purple) and antibodies (grey). Top: After several rounds of replication in host cells, certain intracellular bacteria (green), including L. monocytogenes, have the ability to make an actin tail that can propel them from an infected cell (shown in blue) towards a neighbouring epithelial cell (yellow). This causes part of the infected cell membrane to bulge into the neighbouring cell, which eventually results in the bacteria being taken into the neighbouring cell surrounded by two layers of membrane (one from each cell). Bacteria then break down the two membranes to be released into the cytosol. Bottom: Steele et al. found that F. tularensis and S. enterica can transfer between macrophages through a trogocytosis-associated process. Uninfected macrophages (yellow) acquire bacteria from infected macrophages (blue) following temporary contact between the cells. Afterwards, the cells separate and the bacteria start to replicate in the acceptor cell (blue-yellow; the original blue donor cell is not shown). This bacterial cell-to-cell transfer is also associated with the exchange of membrane, membrane proteins and cytosol.

Using video-microscopy, Steele et al. observed that uninfected macrophages acquire F. tularensis from infected macrophages following a brief cell-to-cell contact. This process does not kill the cells involved, or expose the bacteria to immune responses outside the cells. Moreover, the exchange of materials between two macrophages is not restricted to pathogens that live in the cytosol: Steele et al. demonstrate that macrophages can also exchange latex beads and plasma membrane. The researchers also demonstrate that S. enterica – which lives inside host cell compartments called vacuoles can be transferred between macrophages in the same way. The active exchange of plasma membrane and membrane proteins was first observed in other immune cells called lymphocytes over a decade ago and is called trogocytosis (from the Greek Trogo=to nibble; Joly and Hudrisier, 2003).

The process discovered by Steele et al. joins a list of strategies that bacteria, viruses and other intracellular pathogens are known to use to spread in their host (reviewed in Sattenau, 2008). These other strategies include the fusion of infected cells with surrounding cells, the use of membrane structures that bridge the gaps between cells (Sherer and Mothes, 2008), and the exploitation of the mechanism by which macrophages recognize and engulf dying cells (Czuczman et al., 2014).

Trogocytosis is a normal process that mainly involves macrophages and other immune cells, such as monocytes. It happens more often upon infection, specifically between infected macrophages and their donor cells. This observation suggests that trogocytosis is regulated by individual cells upon infection. A remarkable feature of this process is that membrane proteins that are exchanged between cells – such as the Major Histocompatibility Complex (MHC) molecules, which help to activate immune responses – continue to work properly in their new cell. Therefore, trogocytosis may serve as a surveillance mechanism for the immune system.

The molecular mechanisms underlying trogocytosis and the associated transfer of intracellular bacteria remain to be deciphered. This task will be particularly challenging since it is not currently possible to block trogocytosis with genetic techniques or specific inhibitor drugs. Further experiments are needed to visualize the cellular structures involved in the process, and to understand how the transfer of bacteria is regulated. It will also be important to understand the impact of trogocytosis-associated transfer on other processes, notably innate immune signaling (Ablasser et al., 2013), the presentation of antigens (including the possible transfer of the MHC between cells; Campana et al., 2015), and the spread of the bacteria within the host.

References

Article and author information

Author details

  1. Emilie Bourdonnay

    CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure, CNRS UMR5308, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Thomas Henry

    CIRI-Centre International de Recherche en Infectiologie, Inserm U1111, Université Lyon 1, Ecole Normale Supérieure, CNRS UMR5308, Lyon, France
    For correspondence
    thomas.henry@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published:

Copyright

© 2016, Bourdonnay et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,644
    views
  • 493
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emilie Bourdonnay
  2. Thomas Henry
(2016)
Intracellular Bacteria: Catch me if you can
eLife 5:e14721.
https://doi.org/10.7554/eLife.14721
  1. Further reading

Further reading

    1. Immunology and Inflammation
    Yalan Jiang, Pingping He ... Xiaoou Shan
    Research Article

    Type 1 diabetes mellitus (T1DM), known as insulin-dependent diabetes mellitus, is characterized by persistent hyperglycemia resulting from damage to the pancreatic β cells and an absolute deficiency of insulin, leading to multi-organ involvement and a poor prognosis. The progression of T1DM is significantly influenced by oxidative stress and apoptosis. The natural compound eugenol (EUG) possesses anti-inflammatory, anti-oxidant, and anti-apoptotic properties. However, the potential effects of EUG on T1DM had not been investigated. In this study, we established the streptozotocin (STZ)-induced T1DM mouse model in vivo and STZ-induced pancreatic β cell MIN6 cell model in vitro to investigate the protective effects of EUG on T1DM, and tried to elucidate its potential mechanism. Our findings demonstrated that the intervention of EUG could effectively induce the activation of nuclear factor E2-related factor 2 (NRF2), leading to an up-regulation in the expressions of downstream proteins NQO1 and HMOX1, which are regulated by NRF2. Moreover, this intervention exhibited a significant amelioration in pancreatic β cell damage associated with T1DM, accompanied by an elevation in insulin secretion and a reduction in the expression levels of apoptosis and oxidative stress-related markers. Furthermore, ML385, an NRF2 inhibitor, reversed these effects of EUG. The present study suggested that EUG exerted protective effects on pancreatic β cells in T1DM by attenuating apoptosis and oxidative stress through the activation of the NRF2 signaling pathway. Consequently, EUG holds great promise as a potential therapeutic candidate for T1DM.

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    Peng Li, Sree Pulugulla ... Warren J Leonard
    Short Report

    Transcription factor partners can cooperatively bind to DNA composite elements to augment gene transcription. Here, we report a novel protein-DNA binding screening pipeline, termed Spacing Preference Identification of Composite Elements (SPICE), that can systematically predict protein binding partners and DNA motif spacing preferences. Using SPICE, we successfully identified known composite elements, such as AP1-IRF composite elements (AICEs) and STAT5 tetramers, and also uncovered several novel binding partners, including JUN-IKZF1 composite elements. One such novel interaction was identified at CNS9, an upstream conserved noncoding region in the human IL10 gene, which harbors a non-canonical IKZF1 binding site. We confirmed the cooperative binding of JUN and IKZF1 and showed that the activity of an IL10-luciferase reporter construct in primary B and T cells depended on both this site and the AP1 binding site within this composite element. Overall, our findings reveal an unappreciated global association of IKZF1 and AP1 and establish SPICE as a valuable new pipeline for predicting novel transcription binding complexes.